EAPC in incidence and mortality of LC for age group. by Ze-Xing Zhang (18074512)

Subjects:

Comparison of absolute and relative errors. by Lahoucine Tadoummant (21647670)

Subjects:

Rate of convergence for relative errors. by Lahoucine Tadoummant (21647670)

Subjects:

Cases and deaths of LC from the Chinese Annual Cancer Registry, 2004–2018. by Ze-Xing Zhang (18074512)

Subjects:

(a) Absolute error of the example 3, Y(x,y) for scale level ranging from 2 to 7. by Lahoucine Tadoummant (21647670)

Subjects:

(a) Comparison of the approximate solution with the exact solution for the example 1. by Lahoucine Tadoummant (21647670)

Subjects:

Approximate Y(x,y) for different value of and for test problem 3. by Lahoucine Tadoummant (21647670)

Subjects:

Changes in LC cases and deaths in male and female from 2004 to 2018, decomposed by three population-level determinants: population aging, population growth and epidemiological chan... by Ze-Xing Zhang (18074512)

Subjects:

(a) Comparison of the approximate solution with the exact solution for the example 2. by Lahoucine Tadoummant (21647670)

Subjects:

Projected ASIR and ASMR of LC in China over the next 15 years based on the Bayesian APC model. by Ze-Xing Zhang (18074512)

Subjects:

Data. by Michael C. Payne (2664379)

Subjects:

Prevalence of <i>Wb</i> microfilaremia and circulating filarial antigenemia before and after MDA in annual and semiannual intervention areas. by Michael C. Payne (2664379)

Subjects:

(a) Comparison of the approximate solution X(x,y) with the exact solution of the problem 3. by Lahoucine Tadoummant (21647670)

Subjects:

Changes in Mf (A and B) CFA (C and D) prevalence at baseline, 1, 2 and 3 years after starting MDA. by Michael C. Payne (2664379)

Subjects:

The incidence and mortality data of LC by age group from the Chinese Annual Cancer Registry, 2004–2018. by Ze-Xing Zhang (18074512)

Subjects:

Approximate X(x,y) for different value of and for test problem 3. by Lahoucine Tadoummant (21647670)

Subjects:

(a) Absolute error of the example 3, X(x,y) for scale level ranging from 2 to 7. by Lahoucine Tadoummant (21647670)

Subjects:

Sentinel sites located within areas treated with MDA semiannually (solid red line) or annually (dashed blue line). by Michael C. Payne (2664379)

Subjects:

Directly observed antifilarial drug ingestion rates in semiannual and annual mass drug administration (MDA) areas. by Michael C. Payne (2664379)

Subjects:

Changes in circulating filarial antigen (CFA) prevalence and levels at years 1, 2, and 3 following the start of mass drug administration, with treatment given semiannually (2x/yr)... by Michael C. Payne (2664379)

Subjects: